Sandra M. Gurrola
Insider Reports History
- Location
- Carlsbad, CA
- Signature
- /s/ Sandra Gurrola
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Sandra M. Gurrola:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ernexa Therapeutics Inc. | Sr. VP of Finance | Restricted Stock Units | 0 | $1,084 | $2.48 | 21 Jun 2025 | Direct |
| Ernexa Therapeutics Inc. | Sr. VP of Finance | Common Stock | 110 | $19 | $0.1800 | 21 Jun 2025 | Direct |
| Eterna Therapeutics Inc. | Sr. VP of Finance | Stock Option (Right to buy) | 150,000 | 07 Feb 2025 | Direct |
Insider Reports Filed by Sandra M. Gurrola
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ERNA | Ernexa Therapeutics Inc. | 21 Jun 2025 | 2 | $0 | 4 | Sr. VP of Finance | 07 Jul 2025, 20:00 |
| ERNA | Eterna Therapeutics Inc. | 07 Feb 2025 | 1 | $0 | 4 | Sr. VP of Finance | 10 Feb 2025, 19:00 |
| ERNA | Eterna Therapeutics Inc. | 21 Jun 2024 | 3 | -$349 | 4 | Sr. VP of Finance | 25 Jun 2024, 16:32 |
| ERNA | Eterna Therapeutics Inc. | 26 Apr 2024 | 1 | $0 | 4 | Sr. VP of Finance | 29 Apr 2024, 16:30 |
| ERNA | Eterna Therapeutics Inc. | 21 Jun 2023 | 3 | -$444 | 4 | Vice President of Finance | 23 Jun 2023, 20:30 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 21 Jun 2022 | 3 | -$1,709 | 4 | Vice President of Finance | 23 Jun 2022, 20:31 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 11 Mar 2022 | 1 | $0 | 4/A | Vice President of Finance | 17 Mar 2022, 21:00 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 21 Jun 2021 | 1 | $0 | 4 | Vice President of Finance | 22 Jun 2021, 18:01 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 21 Jun 2021 | 0 | $0 | 3 | Vice President of Finance | 22 Jun 2021, 18:00 |